Germany

CSL inaugurates new R&D center in Germany

15-Sep-2022 By Rachel Arthur

The €150m ($150m) new facility will become CSL’s largest R&D site: with more than 500 employees and a multitude of disciplines.

Germany locks in vaccine manufacturing capacity with GSK, CureVac, BioNTech and others

12-Apr-2022 By Rachel Arthur

Germany has made a series of contracts with vaccine manufacturers to reserve mRNA manufacturing capacity in the country as part of its pandemic preparedness plans.

Sartorius acquires majority stake in CellGenix

05-Jul-2021 By Rachel Arthur

Sartorius is strengthening its product portfolio for cell and gene therapies with the acquisition of a majority stake in German reagent manufacturer CellGenix.

AstraZeneca in deal with Germany’s IDT Biologika to boost vaccine manufacturing capability

11-Feb-2021 By Jane Byrne

AstraZeneca and IDT Biologika are exploring options to accelerate output of finished COVID-19 Vaccine AstraZeneca in the second quarter of 2021 in order to help support Europe’s immediate vaccination needs during the pandemic.

WuXi Biologics acquires first EU drug product facility through Bayer deal

16-Jan-2020 By Ben Hargreaves

WuXi Biologics will add Bayer’s Leverkusen drug product facility, as part of its continued expansion into the European market.

Germany seen as the leader of European pharma industry

31-Oct-2019 By Ben Hargreaves

Research ranks Germany as the leading nation within Europe due to the high rating of its finished production manufacturing and potential for growth.

Merz completes construction of new plant and filling line

17-Sep-2019 By Ben Hargreaves

Merz announces that it has completed the construction of a new plant for its botulinum neurotoxin product and unveils a ‘robot-controlled’ filling line.